Logo image of LGVN

LONGEVERON INC-A (LGVN) Stock Fundamental Analysis

USA - NASDAQ:LGVN - US54303L2034 - Common Stock

0.7171 USD
-0.02 (-3.3%)
Last: 11/11/2025, 8:22:06 PM
0.718 USD
+0 (+0.13%)
Pre-Market: 11/12/2025, 5:58:32 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LGVN. LGVN was compared to 531 industry peers in the Biotechnology industry. While LGVN seems to be doing ok healthwise, there are quite some concerns on its profitability. LGVN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LGVN had negative earnings in the past year.
In the past year LGVN has reported a negative cash flow from operations.
In the past 5 years LGVN always reported negative net income.
In the past 5 years LGVN always reported negative operating cash flow.
LGVN Yearly Net Income VS EBIT VS OCF VS FCFLGVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

LGVN has a worse Return On Assets (-137.18%) than 83.99% of its industry peers.
Looking at the Return On Equity, with a value of -214.14%, LGVN is doing worse than 68.55% of the companies in the same industry.
Industry RankSector Rank
ROA -137.18%
ROE -214.14%
ROIC N/A
ROA(3y)-116.31%
ROA(5y)-85.81%
ROE(3y)-177.95%
ROE(5y)-153.9%
ROIC(3y)N/A
ROIC(5y)N/A
LGVN Yearly ROA, ROE, ROICLGVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 74.88%, LGVN belongs to the top of the industry, outperforming 83.43% of the companies in the same industry.
In the last couple of years the Gross Margin of LGVN has grown nicely.
LGVN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.36%
GM growth 5Y20.42%
LGVN Yearly Profit, Operating, Gross MarginsLGVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

5

2. Health

2.1 Basic Checks

LGVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LGVN has more shares outstanding
Compared to 5 years ago, LGVN has more shares outstanding
There is no outstanding debt for LGVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LGVN Yearly Shares OutstandingLGVN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M
LGVN Yearly Total Debt VS Total AssetsLGVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -13.99, we must say that LGVN is in the distress zone and has some risk of bankruptcy.
LGVN's Altman-Z score of -13.99 is on the low side compared to the rest of the industry. LGVN is outperformed by 77.97% of its industry peers.
There is no outstanding debt for LGVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.99
ROIC/WACCN/A
WACC8.77%
LGVN Yearly LT Debt VS Equity VS FCFLGVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.09 indicates that LGVN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.09, LGVN is doing worse than 74.01% of the companies in the same industry.
LGVN has a Quick Ratio of 2.09. This indicates that LGVN is financially healthy and has no problem in meeting its short term obligations.
LGVN has a worse Quick ratio (2.09) than 72.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
LGVN Yearly Current Assets VS Current LiabilitesLGVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.27% over the past year.
LGVN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.41%.
LGVN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -15.76% yearly.
EPS 1Y (TTM)76.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
Revenue 1Y (TTM)-22.41%
Revenue growth 3Y22.35%
Revenue growth 5Y-15.76%
Sales Q2Q%-82.28%

3.2 Future

The Earnings Per Share is expected to grow by 24.81% on average over the next years. This is a very strong growth
Based on estimates for the next years, LGVN will show a very strong growth in Revenue. The Revenue will grow by 162.69% on average per year.
EPS Next Y71.17%
EPS Next 2Y35.56%
EPS Next 3Y24.81%
EPS Next 5YN/A
Revenue Next Year-41.66%
Revenue Next 2Y-32.85%
Revenue Next 3Y162.69%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LGVN Yearly Revenue VS EstimatesLGVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
LGVN Yearly EPS VS EstimatesLGVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LGVN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LGVN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGVN Price Earnings VS Forward Price EarningsLGVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LGVN Per share dataLGVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

LGVN's earnings are expected to grow with 24.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.56%
EPS Next 3Y24.81%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LGVN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LONGEVERON INC-A

NASDAQ:LGVN (11/11/2025, 8:22:06 PM)

Premarket: 0.718 +0 (+0.13%)

0.7171

-0.02 (-3.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)N/A N/A
Inst Owners6.96%
Inst Owner Change57.5%
Ins Owners8.73%
Ins Owner Change7%
Market Cap15.10M
Revenue(TTM)1.44M
Net Income(TTM)-21.34M
Analysts82.22
Price Target7 (876.15%)
Short Float %7.57%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.86%
Min EPS beat(2)-49.94%
Max EPS beat(2)8.22%
EPS beat(4)1
Avg EPS beat(4)-16.87%
Min EPS beat(4)-49.94%
Max EPS beat(4)8.22%
EPS beat(8)3
Avg EPS beat(8)-18.04%
EPS beat(12)3
Avg EPS beat(12)-16.17%
EPS beat(16)5
Avg EPS beat(16)-11.14%
Revenue beat(2)0
Avg Revenue beat(2)-39.57%
Min Revenue beat(2)-52.82%
Max Revenue beat(2)-26.32%
Revenue beat(4)0
Avg Revenue beat(4)-31.04%
Min Revenue beat(4)-52.82%
Max Revenue beat(4)-7.27%
Revenue beat(8)2
Avg Revenue beat(8)140.83%
Revenue beat(12)2
Avg Revenue beat(12)81.18%
Revenue beat(16)5
Avg Revenue beat(16)72.18%
PT rev (1m)0%
PT rev (3m)-22.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.07%
EPS NY rev (1m)0%
EPS NY rev (3m)8.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-35.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-27.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.51
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)-1.49
EYN/A
EPS(NY)-0.68
Fwd EYN/A
FCF(TTM)-0.83
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS0.07
BVpS0.47
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -137.18%
ROE -214.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.88%
FCFM N/A
ROA(3y)-116.31%
ROA(5y)-85.81%
ROE(3y)-177.95%
ROE(5y)-153.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.36%
GM growth 5Y20.42%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.96%
Cap/Sales 45.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z -13.99
F-Score4
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)90.92%
Cap/Depr(5y)89.88%
Cap/Sales(3y)69.8%
Cap/Sales(5y)62.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
EPS Next Y71.17%
EPS Next 2Y35.56%
EPS Next 3Y24.81%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.41%
Revenue growth 3Y22.35%
Revenue growth 5Y-15.76%
Sales Q2Q%-82.28%
Revenue Next Year-41.66%
Revenue Next 2Y-32.85%
Revenue Next 3Y162.69%
Revenue Next 5YN/A
EBIT growth 1Y-25.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.41%
OCF growth 3YN/A
OCF growth 5YN/A

LONGEVERON INC-A / LGVN FAQ

What is the ChartMill fundamental rating of LONGEVERON INC-A (LGVN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to LGVN.


What is the valuation status for LGVN stock?

ChartMill assigns a valuation rating of 1 / 10 to LONGEVERON INC-A (LGVN). This can be considered as Overvalued.


How profitable is LONGEVERON INC-A (LGVN) stock?

LONGEVERON INC-A (LGVN) has a profitability rating of 1 / 10.


Can you provide the financial health for LGVN stock?

The financial health rating of LONGEVERON INC-A (LGVN) is 5 / 10.